Establishing secure connection…Loading editor…Preparing document…

Research Agreement Clin Win

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Research Agreement Clin Win

This Research Agreement (the Agreement) is entered into as of Effective Date: by and between Client Name: (Client), and Research Institution Name: (Institution). Client and Institution are each a Party and together the Parties.

Recitals

WHEREAS, Client is conducting clinical evaluation for the product or protocol titled: (Study), and desires to retain Institution to perform certain research activities in support of the Study; and

WHEREAS, Institution represents that it has the facilities, qualified personnel and applicable approvals necessary to conduct the research activities described herein under the leadership of Principal Investigator: ; and

WHEREAS, the Parties wish to set forth the terms and conditions under which Institution will perform research services and Client will provide funding and materials.

Scope of Work

Institution shall perform the research activities, data collection, analysis and reporting described below in accordance with applicable law, Institutional Review Board approvals, and standard clinical research practices.

Payment Terms

Client shall pay Institution the fees and expenses set forth below in consideration for performance of the Scope of Work. All payments are subject to the invoicing and documentation requirements in this section.

Late payments shall incur interest equal to: on overdue amounts, calculated monthly until paid in full. Institution shall submit itemized invoices that identify work performed, personnel, dates, and any reimbursable expenses.

Term and Termination

The Term of this Agreement shall commence on Start Date: and shall expire on End Date: unless earlier terminated as provided below.

Either Party may terminate this Agreement for convenience upon written notice to the other Party delivered at least days prior to the effective date of termination. Either Party may also terminate immediately for material breach that remains uncured for thirty (30) days after written notice, or immediately for reasons of participant safety or regulatory noncompliance.

Confidentiality

Each Party shall hold in confidence all Confidential Information disclosed by the other Party and shall not use Confidential Information except as necessary to perform obligations under this Agreement. "Confidential Information" excludes information that is (i) known to the receiving Party at the time of disclosure without obligation of confidentiality, (ii) becomes publicly available through no breach of this Agreement, (iii) is rightfully received from a third party without restriction, or (iv) is independently developed without reference to the disclosing Party's Confidential Information.

Confidentiality obligations shall continue for a period of years following termination or expiration of this Agreement, except with respect to personally identifiable health information which shall be protected in accordance with applicable law.

Data, Intellectual Property and Publications

All raw data generated by Institution in performance of the Scope of Work shall be owned by: subject to any pre-existing rights of third parties and reasonable use rights retained by Institution to fulfill academic obligations.

Compliance, Indemnification and Insurance

Institution shall perform work in compliance with applicable laws, regulations and Institutional Review Board approvals. Each Party shall indemnify, defend and hold harmless the other Party from third-party claims arising from its negligent acts or willful misconduct in connection with this Agreement. Institution shall maintain professional liability and clinical research insurance in amounts customary for comparable institutions and shall provide certificate of insurance upon request.

Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the State of , excluding its conflict of laws rules.

Entire Agreement

This Agreement, together with any appendices, protocols and task orders executed under it, constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings and communications, whether written or oral. Any amendment to this Agreement must be in writing and executed by authorized representatives of both Parties.

Notices

All notices under this Agreement shall be in writing and delivered to the contact persons listed below at the addresses provided. Notices are effective upon receipt.

Client Name:

By:

Date:

Research Institution Name:

By:

Date:

Enter text✕

What the Research Agreement Clin Win Is and When It Applies

The Research Agreement Clin Win is a formal contract that sets terms between a research sponsor, an investigational site, and other parties for clinical research activities. It defines responsibilities for study conduct, participant recruitment, data collection, payment and reimbursement, intellectual property, confidentiality, regulatory compliance, and indemnification. Use this agreement to document the project's scope, milestones, deliverables, data use and retention, and signatures required to begin study activities and access protected health information under HIPAA. The template assumes U.S. governing law and common clinical research practices.

Why a Clear Research Agreement Clin Win Matters

A well-drafted Research Agreement Clin Win reduces legal ambiguity, sets expectations for safety and data handling, clarifies funding and payment timing, and documents responsibilities for regulatory compliance and participant protections under HIPAA and applicable state law.

Why a Clear Research Agreement Clin Win Matters

Typical Parties Who Prepare or Sign a Research Agreement Clin Win

The agreement is primarily prepared by sponsors, contract offices at investigational sites, and legal teams; it is reviewed by investigators and institutional officials before execution.

  • Study sponsors and clinical operations teams responsible for funding, monitoring, and deliverables.
  • Site principal investigators and research coordinators managing protocol execution and participant safety.
  • Institutional offices (contracts, IRB liaisons, finance) that approve budgets, indemnity, and compliance.

After signature, copies should be distributed to the sponsor, site administrator, PI, and compliance office; the signed agreement becomes the primary record for audits and billing.

Who Signs and Why

Principal Investigator

The PI attests to the ability to conduct the study per protocol and supervise human subjects protections; their signature confirms clinical oversight and responsibilities for participant safety and data accuracy.

Authorized Institutional Official

An institutional signatory (contracts officer, research administrator) accepts financial, indemnity, and compliance obligations on behalf of the organization and ensures alignment with institutional policies.

Core Components to Include in a Professional Research Agreement Clin Win

Include clear, enforceable sections that allocate risk, describe services and deliverables, define payment and invoicing, and set rules for data, IP, confidentiality, and termination.

Parties

Full legal names and entity types for sponsor, site, and any third parties; include addresses and authorized signatories for each party to avoid later disputes.

Scope of Work

Detailed protocol reference, tasks to be performed, enrollment targets, milestones, and acceptance criteria for deliverables tied to payments.

Compensation

Payment schedule, invoicing requirements, allowable expenses, payment terms, and audit rights; specify currency and timing.

Confidentiality

Definition of confidential information, permitted uses, duration of obligations, and return or destruction procedures for sensitive data.

Intellectual Property

Ownership of study data, inventions, and publication rights; licensing terms and obligations to assign or protect IP.

Termination & Indemnity

Grounds for termination, notice periods, wind-down responsibilities, liability caps, and indemnification obligations between parties.

Essential Data and Fields to Capture in the Agreement

Legal Names: Entity legal names
Contact Details: Mailing address and email
Protocol ID: Sponsor protocol identifier
Budget Line Items: Payments and expense categories
Effective Date: Start date of obligations
Signature Blocks: Signatory name and title

Step-by-Step: Completing the Research Agreement Clin Win

Follow these sequential steps to prepare, review, and execute the agreement so it aligns with regulatory, institutional, and sponsor requirements.

  • 01
    Draft: Populate parties, scope, budget and timelines
  • 02
    Review: Legal, IRB, and finance review for compliance
  • 03
    Revise: Incorporate comments and resolve open items
  • 04
    Execute: Collect authorized signatures and distribute copies

How to Configure an Online Signing Workflow for This Agreement

Configure an eSignature workflow that preserves audit trails, enforces signer order, and applies appropriate authentication for participant data access.

Field Configuration
Signer Order Set sponsor then site then PI
Authentication Email + SMS or organization SSO
Conditional Fields Show budget exhibits when funding selected
Notifications Auto reminders for unsigned parties

Where to Send or File the Executed Research Agreement Clin Win

After execution, route signed copies to the sponsor, site grants/contracts office, principal investigator, and institutional records for auditing and billing.

  • Sponsor: Sponsor contract repository and legal team
  • Site Contracts: Institutional contracts office and finance
  • Principal Investigator: PI file and study binder
  • Compliance Office: For HIPAA and regulatory oversight

Digital Signing and File Formats to Support

Use a platform that produces tamper-evident signed PDFs, stores complete audit trails, and supports common clinical document formats.

  • Formats: PDF, DOCX, Excel
  • Integrations: Salesforce, NetSuite, Google Workspace
  • Security: AES-256 at rest

Ensure the chosen platform supports HIPAA (BAA available), audit logs with timestamps and IP addresses, and simple export to institutional repositories for audits.

Key Dates to Track in the Research Agreement Clin Win

Track milestones that affect study start, participant enrollment, budget disbursement, reporting, and regulatory filings to avoid delays or compliance gaps.

Effective Date:

Date obligations start; use MM/DD/YYYY

IRB Approval Deadline:

Obtain IRB approval before enrolling subjects

Enrollment Targets:

Milestone dates tied to payments

Reporting Windows:

Adverse event and progress report due dates

Final Closeout:

Final deliverables and final payment schedule

Common Mistakes When Preparing a Research Agreement Clin Win

  • Ambiguous scope that causes disputes over deliverables and payments.
  • Missing regulatory approvals such as IRB approval before start of work.
  • Unclear data ownership leading to IP and publication conflicts.
  • Insufficient budget detail causing invoicing and reimbursement delays.

Potential Penalties and Legal Risks to Monitor

HIPAA Violation: Civil penalties and corrective action
Breach of Contract: Damages and cure obligations
Regulatory Delay: Study suspension risk
Publication Dispute: Injunctive or monetary relief
Audit Findings: Repayment or sanctions
Data Loss: Reputational and legal exposure

Supporting Documents and Export Options to Attach or Generate

Attach protocol exhibits and supporting documents when executing the agreement; ensure final copies are exportable to standard formats for institutional records.

Protocol

Attach the clinical protocol as an exhibit and reference its version and date to avoid scope confusion.

Informed Consent

Include the approved consent form and IRB approval letter; final signed consent should be stored with subject records.

Budget & SOW

Add detailed budget spreadsheets and statement of work as enforceable exhibits to support invoices.

Data Use Agreement

Attach DUA or DPA for PHI and specify data transfer, storage, and destruction requirements.

Example Situations Where Research Agreement Clin Win Is Used

Real-world examples illustrate how organizations apply the agreement to sponsor-site relationships and institutional workflows.

Optica Ventures (COO)

The interface is simple and easy-to-use for our team; more importantly, it is just as easy for our customers.

  • Study documents were routed electronically to reduce execution time.
  • The result was reduced turnaround on sponsor approvals and clearer recordkeeping across site teams.

Fertility Centers of Illinois (Founder)

The airSlate SignNow team has been exceptional, responsive, the API has been great, and we're extremely happy that we chose airSlate SignNow as a company.

  • Electronic execution integrated with internal systems.
  • This improved compliance tracking for IRB submissions and centralized signed agreement storage for audits.

eSignature Pricing and Feature Comparison for Research Agreement Clin Win

Compare common vendor starting prices and feature availability relevant to clinical research workflows; signNow is listed first per vendor comparison conventions.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Frequently Asked Questions About the Research Agreement Clin Win

Answers to common execution, compliance, and signing questions for research agreements executed under U.S. law.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users